BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Atsawarungruangkit A, Chenbhanich J, Dickstein G. C-peptide as a key risk factor for non-alcoholic fatty liver disease in the United States population. World J Gastroenterol 2018; 24(32): 3663-3670 [PMID: 30166861 DOI: 10.3748/wjg.v24.i32.3663]
URL: https://www.wjgnet.com/2308-3840/full/v24/i32/3663.htm
Number Citing Articles
1
Amporn Atsawarungruangkit, Passisd Laoveeravat, Kittichai Promrat. Machine learning models for predicting non-alcoholic fatty liver disease in the general United States population: NHANES databaseWorld Journal of Hepatology 2021; 13(10): 1417-1427 doi: 10.4254/wjh.v13.i10.1417
2
Asieh Mansour, Mohammad Reza Mohajeri-Tehrani, Majid Samadi, Hadis Gerami, Mostafa Qorbani, Nick Bellissimo, Hossein Poustchi, Azita Hekmatdoost. Risk factors for non-alcoholic fatty liver disease-associated hepatic fibrosis in type 2 diabetes patientsActa Diabetologica 2019; 56(11): 1199 doi: 10.1007/s00592-019-01374-x
3
Seda Turgut, Didem Acarer, Hakan Seyit, Naim Pamuk, Hamide Piskinpasa, Evin Bozkur, Mehmet Karabulut, Ilkay Cakir. Insulin-Like Growth Factor-I Might be a Predictor for Severe Non-Alcoholic Fatty Liver Disease in Morbidly Obese PatientsHormone and Metabolic Research 2022; 54(10): 696 doi: 10.1055/a-1856-7014
4
Mark D. Muthiah, Arun J. Sanyal. Burden of Disease due to Nonalcoholic Fatty Liver DiseaseGastroenterology Clinics of North America 2020; 49(1): 1 doi: 10.1016/j.gtc.2019.09.007
5
Xinyuan Zhang, Longgang Zhao, Cami N. Christopher, Fred K. Tabung, Wei Bao, David O. Garcia, Aladdin H. Shadyab, Nazmus Saquib, Marian L. Neuhouser, Lesley F. Tinker, Xuehong Zhang. Association of dietary insulinemic and inflammatory potential with risk of liver cancer and chronic liver disease mortality in postmenopausal women: a prospective cohort studyThe American Journal of Clinical Nutrition 2023; 118(3): 530 doi: 10.1016/j.ajcnut.2023.07.009
6
Kavita Garg, Scott Brackett, Irl B. Hirsch, Satish K. Garg. NAFLD/NASH and DiabetesDiabetes Technology & Therapeutics 2020; 22(S1): S-174 doi: 10.1089/dia.2020.2513
7
Qiumei Zhou, Yulong Wang, Jiajia Wang, Yating Liu, Dehui Qi, Wei Yao, Hui Jiang, Tingting Li, Kaiquan Huang, Wancun Zhang, Xingxing Huo. Prevalence and risk factor analysis for the nonalcoholic fatty liver disease in patients with type 2 diabetes mellitusMedicine 2021; 100(10): e24940 doi: 10.1097/MD.0000000000024940
8
Laurinda Adusu‐Donkor, Emmanuel Kwaku Ofori, Fleischer C. N. Kotey, Francis Kwaku Dogodzi, Wormenor Dziedzorm, Alfred Buabeng, Segla Kwame Bernard, Seth K. Amponsah, Henry Asare‐Anane. Blood C‐peptide concentration as a proxy marker of cardiovascular disease: An observational cross‐sectional studyHealth Science Reports 2023; 6(9) doi: 10.1002/hsr2.1535
9
Hanying Liu, Xiao Li, Xiaodong Han, Yan Zhang, Yanting Gu, Lianjie Sun, Junfeng Han, Yinfang Tu, Yuqian Bao, Wenkun Bai, Haoyong Yu. Simple surrogate equations to predict controlled attenuation parameter values for screening non-alcoholic fatty liver disease in a Chinese populationFrontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.894895
10
Mohammad Hassan Sohouli, Ali Akbar Sayyari, Abolfazl Lari, Ghazaleh Nameni, Mojtaba Lotfi, Somaye Fatahi, Solaleh Saneie, Mihnea‐Alexandru Găman, Farzan Moodi, Pourya Raee, Shahin Aghamiri, Appaji Rayi, Ali Shahriari, Vihan Moodi. Association of dietary insulinaemic potential and odds of non‐alcoholic fatty liver disease among adults: A case–control studyJournal of Human Nutrition and Dietetics 2021; 34(5): 901 doi: 10.1111/jhn.12865
11
Fatma DEMİRBAŞ, Gönül DİNLER ÇALTEPE, Atakan COMBA, Hasan ABBASGULİYEV, Ayhan Gazi  KALAYCI. Evaluation of the relationship between non-alcoholic fatty liver disease and serum c-peptide, c-peptide to glucose and c-peptide to HbA1C ratio in obese childrenJournal of Surgery and Medicine 2020; 4(12): 1128 doi: 10.28982/josam.778883
12
Ningjian Wang, Yuying Wang, Wen Zhang, Yi Chen, Xiaoman Chen, Chiyu Wang, Qing Li, Chi Chen, Boren Jiang, Yingli Lu. C‐peptide is associated with NAFLD inflammatory and fibrotic progression in type 2 diabetesDiabetes/Metabolism Research and Reviews 2020; 36(2) doi: 10.1002/dmrr.3210
13
Khushdeep Bandesh, Muneesh Pal, Abitha Balakrishnan, Pradeep Gautam, Punam Jha, Nikhil Tandon, Beena Pillai, Dwaipayan Bharadwaj. A novel antisense lncRNA, ARBAG harboring an RNA destabilizing GWAS variant for C-peptide dictates the transcript isoforms of GABRA6 in cerebellumHuman Molecular Genetics 2023; 32(19): 2929 doi: 10.1093/hmg/ddad119
14
Hui‐Huan Luo, Meng‐Di Zhao, Xiao‐Fei Feng, Xiao‐Qian Gao, Mo Hong, Ming‐Li Liu, Yan‐Ping Li, Wan‐Qiu Liu, Yu‐Mo Liu, Cheng‐Cheng Yu, Yun‐Feng Cao, Xi‐Lin Yang, Zhong‐Ze Fang, Ping Zhang. Decreased plasma n6 : n3 polyunsaturated fatty acids ratio interacting with high C‐peptide promotes non‐alcoholic fatty liver disease in type 2 diabetes patientsJournal of Diabetes Investigation 2021; 12(7): 1263 doi: 10.1111/jdi.13469
15
Chifa Ma, Yiwen Liu, Shuli He, Jingbo Zeng, Pingping Li, Chunxiao Ma, Fan Ping, Huabing Zhang, Lingling Xu, Wei Li, Yuxiu Li. C-Peptide: A Mediator of the Association Between Serum Uric Acid to Creatinine Ratio and Non-Alcoholic Fatty Liver Disease in a Chinese Population With Normal Serum Uric Acid LevelsFrontiers in Endocrinology 2020; 11 doi: 10.3389/fendo.2020.600472
16
Enfa Zhao, Shimin Chen. Association of serum C-peptide with all-cause and cardiovascular disease mortality in ultrasound-defined nonalcoholic fatty liver diseaseClinics and Research in Hepatology and Gastroenterology 2022; 46(10): 102002 doi: 10.1016/j.clinre.2022.102002
17
Yujuan Zhang, Liulan Xiang, Fang Qi, Yutian Cao, Wenhui Zhang, Tiansu Lv, Xiqiao Zhou. The metabolic profiles and body composition of non-obese metabolic associated fatty liver diseaseFrontiers in Endocrinology 2024; 15 doi: 10.3389/fendo.2024.1322563
18
雅静 黄. C-Peptide and Non-Alcoholic Fatty Liver Disease in Type 2 DiabetesAdvances in Clinical Medicine 2021; 11(04): 1649 doi: 10.12677/ACM.2021.114237
19
Rou Shi, Chunwen Lin, Yaping Hong, Xiaoying Xia, Yingjian Chen, Shu Li, Liangchang Xiu, Zhenbo Xu. Free Triiodothyronine Is Independently Associated with Nonalcoholic Fatty Liver Disease in Hospitalized Type 2 Diabetes Mellitus PatientsBioMed Research International 2021; 2021: 1 doi: 10.1155/2021/8868339